Free Trial
OTCMKTS:RCDTF

Recordati Industria Chimica E Farmaceutica Q1 2026 Earnings Results & Report

Recordati Industria Chimica E Farmaceutica logo
$58.79 0.00 (0.00%)
As of 11/13/2026

Recordati Industria Chimica E Farmaceutica reported Q1 2026 earnings on May 13, 2026. The company reported EPS of $1.08, while revenue was $834.86 million.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
Before Market Opens

Recordati Industria Chimica E Farmaceutica EPS Results

Actual EPS
$1.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Recordati Industria Chimica E Farmaceutica Revenue Results

Actual Revenue
$834.86 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Recordati Industria Chimica E Farmaceutica Q1 2026 Earnings FAQ

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) reported earnings of $1.08 per share for Q1 2026. The report was announced on Wednesday, May 13, 2026.

Recordati Industria Chimica E Farmaceutica reported revenue of $834.86 million for Q1 2026.

Recordati Industria Chimica E Farmaceutica Earnings Headlines

Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Respighi BidCo Raises Recordati Stake Above 74%
See More Recordati Industria Chimica E Farmaceutica Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Recordati Industria Chimica E Farmaceutica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Recordati Industria Chimica E Farmaceutica and other key companies, straight to your email.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) is an Italian pharmaceutical company founded in 1926 and headquartered in Milan. It develops, manufactures and commercializes medicines, with businesses spanning specialty and primary-care treatments as well as medicines for rare diseases.

Its products address a range of therapeutic areas, including endocrinology, urology, cardiovascular medicine and other specialist fields. Through its rare-disease business, Recordati also provides treatments for patients with uncommon and complex conditions.

The company serves markets in Europe and other regions worldwide, selling its medicines through its own commercial operations and partners. Its international business has expanded over time through acquisitions, including the addition of EUSA Pharma, which strengthened its rare-disease portfolio.

View Recordati Industria Chimica E Farmaceutica Profile